Related Experiment Video
Updated: Jun 15, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Efficacy and safety of colonic stenting for malignant disease in the elderly
Fergal Donnellan1, Garret Cullen, Daniel Cagney
1Department of Gastroenterology, Beaumont Hospital, Dublin, Ireland. fdonnellan77@hotmail.com
Background:
Self-expandable metal stents (SEMS) are an accepted palliation for malignant colorectal obstruction. Outcomes of stent insertion solely in older patients are unknown.
Objective:
To compare outcomes of SEMS insertion for malignant colorectal disease, in older versus younger patients.
Methods:
Forty-three patients were retrospectively identified as having undergone SEMS insertion for obstructing colorectal cancer. Of these, 24 were > or = 70 years of age (older patient group) and 19 were <70 years of age (younger patient group).
Results:
There was no significant difference in successful SEMS insertion between the groups (88% in older versus 100% in younger patients, p > 0.05). Furthermore, the complication rate was similar in both groups (12.5% versus 26%, p > 0.10). There was no difference in median survival (113 days versus 135 days, p > 0.09).
Conclusion:
Colorectal stenting for malignant disease in older patients is both safe and effective with comparative success and complication rates to a younger population.